Multiple outlets report on a new approach described by researchers as an AI-enabled “vaccine” designed to protect against a wide range of viruses, including viruses cited such as Covid-19 and Ebola. The coverage characterizes the method as a technology that could be used to address potential pandemic threats before they become widespread, by targeting or adapting to new viral variants and mutations. The articles describe the work as “future-proofed,” suggesting the platform is intended to remain effective as viruses evolve. However, the reporting does not provide shared details across outlets on whether the system has been tested in humans, what specific immune targets it uses, or what performance results have been observed beyond the researchers’ claims. The information presented focuses on the promise of broad, adaptable protection rather than specific clinical efficacy data or regulatory milestones. As described in the articles, the concept relies on AI-driven design or planning to support vaccine development for multiple emerging threats.